179 related articles for article (PubMed ID: 20214788)
1. The AP-1 repressor protein, JDP2, potentiates hepatocellular carcinoma in mice.
Bitton-Worms K; Pikarsky E; Aronheim A
Mol Cancer; 2010 Mar; 9():54. PubMed ID: 20214788
[TBL] [Abstract][Full Text] [Related]
2. The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice.
Trierweiler C; Hockenjos B; Zatloukal K; Thimme R; Blum HE; Wagner EF; Hasselblatt P
Cell Death Differ; 2016 Apr; 23(4):576-82. PubMed ID: 26470729
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of AP-1 signaling by JDP2 overexpression protects cardiomyocytes against hypertrophy and apoptosis induction.
Hill C; Würfel A; Heger J; Meyering B; Schlüter KD; Weber M; Ferdinandy P; Aronheim A; Schulz R; Euler G
Cardiovasc Res; 2013 Jul; 99(1):121-8. PubMed ID: 23612584
[TBL] [Abstract][Full Text] [Related]
4. Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver.
Wu Y; Wang YY; Nakamoto Y; Li YY; Baba T; Kaneko S; Fujii C; Mukaida N
Oncogene; 2010 Apr; 29(15):2228-37. PubMed ID: 20101231
[TBL] [Abstract][Full Text] [Related]
5. The expression of a tumor suppressor gene JDP2 and its prognostic value in hepatocellular carcinoma patients.
Chen YL; Chan SH; Lin PY; Chu PY
Hum Pathol; 2017 May; 63():212-216. PubMed ID: 28315425
[TBL] [Abstract][Full Text] [Related]
6. Histone chaperone Jun dimerization protein 2 (JDP2): role in cellular senescence and aging.
Huang YC; Saito S; Yokoyama KK
Kaohsiung J Med Sci; 2010 Oct; 26(10):515-31. PubMed ID: 20950777
[TBL] [Abstract][Full Text] [Related]
7. Cloning and characterization of the mouse JDP2 gene promoter reveal negative regulation by p53.
Xu Y; Jin C; Liu Z; Pan J; Li H; Zhang Z; Bi S; Yokoyama KK
Biochem Biophys Res Commun; 2014 Aug; 450(4):1531-6. PubMed ID: 25026555
[TBL] [Abstract][Full Text] [Related]
8. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
Ritorto MS; Borlak J
J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
[TBL] [Abstract][Full Text] [Related]
9. Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model.
Cooper SJ; MacGowan J; Ranger-Moore J; Young MR; Colburn NH; Bowden GT
Mol Cancer Res; 2003 Sep; 1(11):848-54. PubMed ID: 14517347
[TBL] [Abstract][Full Text] [Related]
10. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
Chuĭkin IA; Lianguzova MS; Pospelov VA
Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
[TBL] [Abstract][Full Text] [Related]
11. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
12. JDP2, a repressor of AP-1, recruits a histone deacetylase 3 complex to inhibit the retinoic acid-induced differentiation of F9 cells.
Jin C; Li H; Murata T; Sun K; Horikoshi M; Chiu R; Yokoyama KK
Mol Cell Biol; 2002 Jul; 22(13):4815-26. PubMed ID: 12052888
[TBL] [Abstract][Full Text] [Related]
13. JDP2 suppresses adipocyte differentiation by regulating histone acetylation.
Nakade K; Pan J; Yoshiki A; Ugai H; Kimura M; Liu B; Li H; Obata Y; Iwama M; Itohara S; Murata T; Yokoyama KK
Cell Death Differ; 2007 Aug; 14(8):1398-405. PubMed ID: 17464331
[TBL] [Abstract][Full Text] [Related]
14. c-JUN Dimerization Protein 2 (JDP2) Is a Transcriptional Repressor of Follicle-stimulating Hormone β (FSHβ) and Is Required for Preventing Premature Reproductive Senescence in Female Mice.
Jonak CR; Lainez NM; Roybal LL; Williamson AD; Coss D
J Biol Chem; 2017 Feb; 292(7):2646-2659. PubMed ID: 28007961
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress enhances AP-1 and NF-κB-mediated regulation of β(2)-glycoprotein I gene expression in hepatoma cells.
Chiu WC; Chen CJ; Lee TS; Chen ZJ; Ke PH; Chiang AN
J Cell Biochem; 2010 Nov; 111(4):988-98. PubMed ID: 20665665
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
[TBL] [Abstract][Full Text] [Related]
17. The c-Jun dimerization protein 2 inhibits cell transformation and acts as a tumor suppressor gene.
Heinrich R; Livne E; Ben-Izhak O; Aronheim A
J Biol Chem; 2004 Feb; 279(7):5708-15. PubMed ID: 14627710
[TBL] [Abstract][Full Text] [Related]
18. Regulation of histone acetylation and nucleosome assembly by transcription factor JDP2.
Jin C; Kato K; Chimura T; Yamasaki T; Nakade K; Murata T; Li H; Pan J; Zhao M; Sun K; Chiu R; Ito T; Nagata K; Horikoshi M; Yokoyama KK
Nat Struct Mol Biol; 2006 Apr; 13(4):331-8. PubMed ID: 16518400
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice.
Deane NG; Parker MA; Aramandla R; Diehl L; Lee WJ; Washington MK; Nanney LB; Shyr Y; Beauchamp RD
Cancer Res; 2001 Jul; 61(14):5389-95. PubMed ID: 11454681
[TBL] [Abstract][Full Text] [Related]
20. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells.
Kim Y; Yoon JW; Xiao X; Dean NM; Monia BP; Marcusson EG
Cancer Res; 2007 Apr; 67(8):3583-93. PubMed ID: 17440069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]